{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:42:00Z","timestamp":1794714120260,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016040","name":"Takeda Canada Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016040","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The evolving nature of multiple myeloma (MM) therapies, including the introduction of novel oral agents, has produced a shift in the delivery of care from hospital to home. Within this context, patients and their caregivers are becoming increasingly engaged in the work of illness management, however the exact nature of this work as well as the ways in which this work informs treatment preferences and decisions within this population has not been explored. This qualitative study sought to develop an in-depth understanding of patient and caregiver experiences with different MM treatments, the work necessitated by MM and treatment management, and the processes of patient\/caregiver treatment-related decision making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Qualitative interviews were conducted with 16 MM patients and 8 caregivers. Interviews were coded for emergent themes and patterns and a constant comparative approach was used to identify important similarities and differences within and between interviews.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patient and caregiver participants described four types of work, including the work of accruing and personalizing medical knowledge, illness-related work in the hospital, illness-related work in the home, and psychosocial and relational management. They illuminated the physical, psychological, social and relational toll of this work and traced a pathway through which work informed their treatment-related decisions, sometimes in ways that conflicted with their preferences for treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The work involved in managing MM, its treatment, and side-effects can inform the treatment decisions that patients and caregivers make. We must continue to find meaningful ways for patients and caregivers to discuss goals of care and treatment throughout the cancer trajectory, as well as support health care providers in the delivery of person-centred cancer care. With an increasing emphasis on the importance of shared decision making in MM, an improved understanding of the factors that frame patient\u2019s and caregiver\u2019s treatment decisions will be paramount to ensuring meaningful and high-quality patient-centered care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-021-08527-8","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T15:02:43Z","timestamp":1625756563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The work of managing multiple myeloma and its implications for treatment-related decision making: a qualitative study of patient and caregiver experiences"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9627-7562","authenticated-orcid":false,"given":"Cheryl","family":"Pritlove","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobin","family":"Jassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arleigh","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,8]]},"reference":[{"issue":"1","key":"8527_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0609.2010.01542.x","volume":"86","author":"MA Dimopoulos","year":"2011","unstructured":"Dimopoulos MA, San-Miguel JF, Anderson KC. Emerging therapies for the treatment of relapsed or refractory multiple myeloma. Eur J Haematol. 2011;86(1):1\u201315. https:\/\/doi.org\/10.1111\/j.1600-0609.2010.01542.x.","journal-title":"Eur J Haematol"},{"key":"8527_CR2","volume-title":"Multiple Myeloma","author":"Canadian Cancer Society","year":"2020","unstructured":"Canadian Cancer Society. 2020. Multiple Myeloma. Retrieved from https:\/\/www.cancer.ca\/en\/cancer-information\/cancer-type\/multiple-myeloma\/statistics\/?region=on"},{"key":"8527_CR3","unstructured":"Canadian Cancer Society. Survival statistics for multiple myeloma. http:\/\/www.cancer.ca\/en\/cancer-information\/cancer-type\/multiple-myeloma\/prognosis-and-survival\/survival-statistics\/?region=on. Published 2018."},{"issue":"5","key":"8527_CR4","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","volume":"111","author":"SK Kumar","year":"2012","unstructured":"Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, et al. Improved survival in multiple myeloma and the impact of novel therapies improved survival in multiple myeloma and the impact of novel therapies. Survival (Lond). 2012;111(5):2516\u201320. https:\/\/doi.org\/10.1182\/blood-2007-10-116129.","journal-title":"Survival (Lond)"},{"issue":"1","key":"8527_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ejh.12882","volume":"99","author":"L Kongsgaard Nielsen","year":"2017","unstructured":"Kongsgaard Nielsen L, Jarden M, Lykkegaard Andersen C, Frederiksen H, Abildaard N. A systematic review of health-related quality of life in longitudinal studies of myeloma patients. Eur J Haematol. 2017;99(1):3\u201317.8. https:\/\/doi.org\/10.1111\/ejh.12882.","journal-title":"Eur J Haematol"},{"key":"8527_CR6","first-page":"4","volume":"6","author":"E Blackburn","year":"2016","unstructured":"Blackburn E. Multiple myeloma gets three new drugs. Cancer Discov. 2016;6:4.","journal-title":"Cancer Discov"},{"issue":"6","key":"8527_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1188\/13.CJON.S2.25-32","volume":"17","author":"S Kurtin","year":"2013","unstructured":"Kurtin S, Lilleby K, Spong J. Caregivers of multiple myeloma survivors. Clin J Oncol Nurs. 2013;17(6):25\u201330. https:\/\/doi.org\/10.1188\/13.CJON.S2.25-32.","journal-title":"Clin J Oncol Nurs"},{"issue":"3","key":"8527_CR8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.soncn.2017.05.010","volume":"33","author":"M Morris","year":"2017","unstructured":"Morris M, Marshall-Lucette S. The experience of myeloma caregivers during home-based Oral chemotherapy treatment: a qualitative study. Semin Oncol Nurs. 2017;33(3):362\u201371. https:\/\/doi.org\/10.1016\/j.soncn.2017.05.010.","journal-title":"Semin Oncol Nurs"},{"issue":"1","key":"8527_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/1472-6963-14-281","volume":"14","author":"CR May","year":"2014","unstructured":"May CR, Eton DT, Boehmer K, Gallacher K, Hunt K, MacDonald S, et al. Rethinking the patient: using burden of treatment theory to understand the changing dynamics of illness. BMC Health Serv Res. 2014;14(1):281\u201392. https:\/\/doi.org\/10.1186\/1472-6963-14-281.","journal-title":"BMC Health Serv Res"},{"key":"8527_CR10","volume-title":"Theorizing Women\u2019s work","author":"P Armstrong","year":"1990","unstructured":"Armstrong P, Armstrong H. Theorizing Women\u2019s work. Toronto: University of Toronto Press; 1990."},{"key":"8527_CR11","volume-title":"Thinking women and health care reform in Canada","author":"P Armstrong","year":"2012","unstructured":"Armstrong P, Clow B, Grant K, Haworth-Brockman M, Jackson B, Pederson A, et al. Thinking women and health care reform in Canada. Toronto: Women\u2019s Press; 2012."},{"issue":"5","key":"8527_CR12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1177\/1049732318803885","volume":"29","author":"C Pritlove","year":"2019","unstructured":"Pritlove C, Safai P, Angus J, Armstrong P, Jones J, Parsons J. \u201cIt\u2019s hard work\u201d: a feminist political economy approach to Reconceptualizing \u201cwork\u201d in the Cancer context. Qual Health Res. 2019;29(5):758\u201373. https:\/\/doi.org\/10.1177\/1049732318803885.","journal-title":"Qual Health Res"},{"issue":"5","key":"8527_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.clml.2017.02.024","volume":"17","author":"SK Kumar","year":"2017","unstructured":"Kumar SK, Vij R, Noga SJ, Berg D, Brent L, Dollar L, et al. Treating multiple myeloma patients with Oral therapies. Clin Lymphoma Myeloma Leuk. 2017;17(5):243\u201351. https:\/\/doi.org\/10.1016\/j.clml.2017.02.024.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"8527_CR14","doi-asserted-by":"crossref","unstructured":"Osborne TR, Ramsenthaler C, de Wolf-Linder S, Schey SA, Siegert RJ, Edmonds PM, et al. Understanding what matters most to people with multiple myeloma: a qualitative study of views on quality of life. BMC Cancer. 2014;14:\u2013496.","DOI":"10.1186\/1471-2407-14-496"},{"issue":"2\u20133","key":"8527_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ctrc.2014.08.003","volume":"2","author":"JD Tariman","year":"2014","unstructured":"Tariman JD, Doorenbos A, Schepp KG, Becker PS, Berry DL. Patient, physician contextual factors are influential in treatment decision making of older adults newly diagnosed with symptomatic myeloma. Cancer Treat Commun. 2014;2(2\u20133):34\u201347. https:\/\/doi.org\/10.1016\/j.ctrc.2014.08.003.","journal-title":"Cancer Treat Commun"},{"issue":"2","key":"8527_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1078-1439(02)00209-0","volume":"21","author":"DL Berry","year":"2003","unstructured":"Berry DL, Ellis WJ, Woods NF, Schwein C, Mullen KH, Yang C. Treatment decision-making by men with localized prostate cancer: the influence of personal factors. Urol Oncol. 2003;21(2):93\u2013100. https:\/\/doi.org\/10.1016\/S1078-1439(02)00209-0.","journal-title":"Urol Oncol"},{"issue":"5","key":"8527_CR17","first-page":"e121","volume":"16","author":"SB Zeliadt","year":"2010","unstructured":"Zeliadt SB, Moinpour CM, Blough DK, Penson DF, Hall IJ, Smith JL. Preliminary treatment considerations among men with newly diagnosed prostate cancer. Am J Manag Care. 2010;16(5):e121\u201330.","journal-title":"Am J Manag Care"},{"issue":"1","key":"8527_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12885-019-5467-x","volume":"19","author":"JA Parsons","year":"2019","unstructured":"Parsons JA, Greenspan NR, Baker NA, McKillop C, Hicks LK, Chan O. Treatment preferences of patients with relapsed and refractory multiple myeloma: a qualitative study. BMC Cancer. 2019;19(1):264. https:\/\/doi.org\/10.1186\/s12885-019-5467-x.","journal-title":"BMC Cancer"},{"key":"8527_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2147\/PPA.S241340","volume":"14","author":"W-Y Jen","year":"2020","unstructured":"Jen W-Y, Yoong J, Liu X, Si Yun Tan M, Chng WJ, Chee Y-L. Qualitative study of factors affecting patient, caregiver and physician preferences for treatment of myeloma and indolent lymphoma. Patient Prefer Adherence. 2020;14:301\u20138. https:\/\/doi.org\/10.2147\/PPA.S241340.","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"8527_CR20","first-page":"5662","volume":"130","author":"D Auclair","year":"2017","unstructured":"Auclair D, Mansfield C, Chari A, Cole CE, Fiala MA, Kaufman JL, et al. Understanding the preferences of patients and caregivers for relapsed\/refractory multiple myeloma treatment: a mixed-mode patient-centric approach. Blood. 2017;130(1):5662.","journal-title":"Blood."},{"key":"8527_CR21","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.2147\/PPA.S183187","volume":"12","author":"T Wilke","year":"2018","unstructured":"Wilke T, Mueller S, Bauer S, Pitura S, Probst L, Ratsch BA, et al. Treatment of relapsed refractory multiple myeloma: which new PI-based combination treatments do patients prefer? Patient Prefer Adherence. 2018;12:2387\u201396. https:\/\/doi.org\/10.2147\/PPA.S183187.","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"8527_CR22","first-page":"26","volume":"13","author":"K Giusti","year":"2017","unstructured":"Giusti K, Young AQ, Winget M, Lehrhaupt K. Understanding difference in critical decisions in the multiple myeloma patient journey in the era of precision medicine. J Hematol Oncol. 2017;13(3):26\u201337.","journal-title":"J Hematol Oncol"},{"key":"8527_CR23","volume-title":"Encyclopaedia of Statistical Sciences","author":"S Berg","year":"1988","unstructured":"Berg S. Snowball sampling. In: Kotz S, Johnson NL, editors. Encyclopaedia of Statistical Sciences, vol. 8; 1988."},{"issue":"2","key":"8527_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/160940690200100202","volume":"1","author":"JM Morse","year":"2002","unstructured":"Morse JM, Barrett M, Myan M, Olson K, Spiers J. Verification strategies for establishing reliability and validity in qualitative research. Int J Qual Methods. 2002;1(2):1\u201319.","journal-title":"Int J Qual Methods"},{"issue":"2","key":"8527_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/1525822X980100020301","volume":"10","author":"KM MacQueen","year":"1998","unstructured":"MacQueen KM, McLellan E, Kay K, Milstein B. Codebook development for team based qualitative analysis. CAM J. 1998;10(2):31\u20136. https:\/\/doi.org\/10.1177\/1525822X980100020301.","journal-title":"CAM J"},{"issue":"4","key":"8527_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1023\/A:1020909529486","volume":"36","author":"H Boeije","year":"2002","unstructured":"Boeije H. A purposeful approach to the constant comparative method in the analysis of qualitative interviews. Qual Quant. 2002;36(4):391\u2013409. https:\/\/doi.org\/10.1023\/A:1020909529486.","journal-title":"Qual Quant"},{"issue":"4","key":"8527_CR27","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","volume":"52","author":"B Saunders","year":"2018","unstructured":"Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893\u2013907. https:\/\/doi.org\/10.1007\/s11135-017-0574-8.","journal-title":"Qual Quant"},{"key":"8527_CR28","first-page":"33","volume-title":"Doing Qualitative Research","author":"AJ Kuzel","year":"1999","unstructured":"Kuzel AJ. Sampling in qualitative inquiry. In: Crabtree BF, Miller WL, editors. Doing Qualitative Research. 2nd ed. Thousand Oaks: Sage Publications, Inc; 1999. p. 33\u201345.","edition":"2"},{"issue":"5","key":"8527_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1548-5315(11)70702-1","volume":"3","author":"BD Bultz","year":"2006","unstructured":"Bultz BD, Holland JC. Emotional distress in patients with cancer: the sixth vital sign. Commun Oncol. 2006;3(5):311\u20134. https:\/\/doi.org\/10.1016\/S1548-5315(11)70702-1.","journal-title":"Commun Oncol"},{"issue":"8","key":"8527_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00520-009-0615-5","volume":"17","author":"JD Harrison","year":"2009","unstructured":"Harrison JD, Young JM, Price MA, Butow PN, Solomon MJ. What are the unmet supportive care needs of people with cancer? A systematic review. Support Care Cancer. 2009;17(8):117\u201328.","journal-title":"Support Care Cancer"},{"issue":"3","key":"8527_CR31","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.ygyno.2011.10.037","volume":"124","author":"JM Jones","year":"2012","unstructured":"Jones JM, Ferguson S, Edwards E, Walton T, McCurdy N, Howell D. Experiences of care delivery: endometrial cancer survivors at end of treatment. J Gynecol Oncol. 2012;124(3):458\u201364. https:\/\/doi.org\/10.1016\/j.ygyno.2011.10.037.","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"8527_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/(SICI)1099-1611(200003\/04)9:2<147::AID-PON443>3.0.CO;2-X","volume":"9","author":"SM Dowsett","year":"2000","unstructured":"Dowsett SM, Saul JL, Butow PN, Dunn SM, Boyer MJ, Findlow R, et al. Communication styles in the cancer consultation: preferences for a patient-centred approach. Psycho-oncol. 2000;9(2):147\u201356. https:\/\/doi.org\/10.1002\/(SICI)1099-1611(200003\/04)9:2<147::AID-PON443>3.0.CO;2-X.","journal-title":"Psycho-oncol."},{"key":"8527_CR33","volume-title":"WHO global strategy on people-centred and integrated health services 2015","author":"World Health Organization","year":"2015","unstructured":"World Health Organization . (2015). WHO global strategy on people-centred and integrated health services 2015. http:\/\/apps.who.int\/iris\/bitstream\/10665\/155002\/1\/WHO_HIS_SDS_2015.6_eng.pdf."},{"key":"8527_CR34","volume-title":"Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis","author":"Committee on Improving the Quality of Cancer Care","year":"2013","unstructured":"Committee on Improving the Quality of Cancer Care. Addressing the Challenges of an Aging Population; Board on Health Care Services; Institute of Medicine. In: Levit L, Balogh E, Nass S, et al., editors. Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis, vol. 3. Washington (DC): National Academies Press (US); 2013. Patient-Centered Communication and Shared Decision Making. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK202146\/."},{"issue":"9","key":"8527_CR35","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.pec.2019.04.028","volume":"102","author":"TW LeBlanc","year":"2019","unstructured":"LeBlanc TW, Baile WF, Eggly S, Bylund CL, Kurtin S, Khurana M, et al. Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies. Patient Educ Couns. 2019;102(9):1602\u201312. https:\/\/doi.org\/10.1016\/j.pec.2019.04.028.","journal-title":"Patient Educ Couns"},{"issue":"2","key":"8527_CR36","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4081\/oncol.2018.374","volume":"12","author":"MS Islam","year":"2018","unstructured":"Islam MS. Treat patient, not just the disease: holistic needs assessment for haematological cancer patients. Oncol Rev. 2018;12(2):374. https:\/\/doi.org\/10.4081\/oncol.2018.374.","journal-title":"Oncol Rev"},{"issue":"10","key":"8527_CR37","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/pon.3284","volume":"22","author":"J Lamers","year":"2013","unstructured":"Lamers J, Hartmann M, Goldschmidt H, Brechtel A, Hillengass J, Herzog W. Psychosocial support in patients with multiple myeloma at time of diagnosis: who wants what? Psycho-oncol. 2013;22(10):2313\u201320. https:\/\/doi.org\/10.1002\/pon.3284.","journal-title":"Psycho-oncol."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08527-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08527-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08527-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T15:04:07Z","timestamp":1625756647000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08527-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,8]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8527"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08527-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-92579\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,8]]},"assertion":[{"value":"4 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Given the national reach of the study, most interviews were conducted over the phone, requiring us to obtain verbal consent (in place of written consent). All eligible participants provided verbal informed consent prior to participating in the interview. Ethical approval for the study, including the consent process, was provided by the Research Ethics Board of St. Michael\u2019s Hospital (January 9, 2019, REB# 18\u2013320).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided consent to publish their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CP has received research funding through her institution from Takeda Canada Inc. AM has received honorarium from Janssen and Celgene for speaking at symposiums. She also sits on advisory boards for Janssen, Celgene, Takeda, Amgen, Galaxo Smilth Kline, and Sanofi. BB was an employee of Takeda Canada at the time of study development and an employee of Roche Canada at the time of data analysis and manuscript development.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"793"}}